April, 06 2026 Monday 19:21 Hrs
Last update 11-9-2025
  • SENSEX :   74,106.85

  • Commodity broking firm in India787.30( 1.07%) 06-Apr-2026
top-arrow-market
Sensex 74106.85 787.30  (1.07) 06-Apr-2026
Previous Day Close
73319.55
Today's High/Low
High Low
  •  
  •  
74207.46 72728.66

Company News Details

Industry :  
BSE Code
ISIN Demat
Book Value()
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
EPS(TTM)
Face Value()
Div & Yield %
 

25006010155
Biocon Biologics announces settlement agreement with Amgen Inc.
Dec 02,2025

Biocon Biologics, a subsidiary of Biocon, announced a settlement agreement with Amgen Inc. that clears the path for the commercialization of its Denosumab biosimilars in Europe and the rest of the world.

The agreement allows Biocon Biologics to commercialize both its Denosumab biosimilars (Vevzuo® and Evfraxy®) in Europe starting 02 December 2025. The other terms of the settlement remain confidential.

Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.